Subtilisin
Based on 1 Customer Validation
Subtilisin (EC 3.4.21.14) is a bacterial serine protease. Subtilisin induces Apoptosis. Subtilisin stimulates the expression of pro-allergic cytokines (IL-1α, IL-33). Subtilisin induces prototypic allergic lung inflammation. Subtilisin exhibits anticancer activity against breast and colon cancer. Subtilisin shows antifouling activity. Subtilisin can be used as a detergent additive.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 9014-01-1
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
Product Information
It is a proteolytic enzyme made by deep fermentation, extraction and purification of Bacillus subtilis selected by protoplast mutagenesis method. It can hydrolyze the peptide chain of protein molecules to generate polypeptides or amino acids. It can also catalyze the synthesis of polypeptides in organic solvents. This product contains stabilizers.
Effective temperature range: 20-60°C, the optimum temperature is between 35-45°C.
Effective pH range: 6.0-11.0, the optimum pH range is between 9.5-10.5.
Activators: Ca2+, Mg2+, Mn2+, Zn2+, Fe2+.
Inhibitors: Reagents acting on serine such as sulfonyl halides.
Instructions
Soluble in 100 mg/mL ddH2O, avoid repeated freezing and thawing, or dissolve according to specific experimental references.
Subtilisin (3-5 μg/mL; 24 h) shows cytotoxic effects in MCF-7 and HT-29 cancer cells, with MCF-7 cells showing apoptotic cell characteristics and HT-29 cells showing necrotic cell characteristics[1].
Subtilisin shows antifouling activity[2].
Subtilisin (1.0-10 μg/mL; 3-6 h) stimulates the expression of pro-allergic cytokines IL-1α, IL-33, TSLP, and the growth factor amphiregulin in H292 cells[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MCF-7
-
Concentration:0 μg/mL, 3 μg/mL, 5 μg/mL
-
Incubation Time:24 h
-
Result:Increased apoptotic rate.
Showed no changes in the levels of pro-apoptotic protein Bax and anti-apoptotic protein Bcl-2.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female C57BL/6 mice (8-12 weeks old), allergic airway disease model[4]
-
Dosage:1 μg
-
Administration:Subcutaneous (s.c.) or intranasal (i.n.). Sensitization: s.c. or i.n. injection with 1 μg of subtilisin on days 0 and 7. Challenge: i.n. administration with 1 μg of subtilisin on days 14 and 21. whole experimental cycle of 22 days
-
Result:Induced high levels of serum IgE and specific IgG1.
Led to intense airway eosinophilic inflammation, as shown by total and differential cell counts in bronchoalveolar lavage (BAL).
Induced pronounced airway inflammation and mucus formation.
Promoted increased bronchoconstriction to inhaled methacholine and induced a late-phase response.
Induced allergic responses dependent on its protease activity, protease-activated receptor (PAR)-2, IL-33 receptor ST2, and MyD88 signaling.
EC Number
3.4.21.62
Enzyme Activity
≥150 U/mg soild
Unit Definition
One unit is defined as the amount of enzyme that can hydrolyze casein to produce 1 μg of tyrosine per min at pH 10 and 40°C
Chemical Information
-
CAS No. 9014-01-1
-
Appearance Solid
-
Color Light yellow to light brown
-
SMILES
[Subtilisin]
-
Synonyms
EC 3.4.21.14
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Solvant et solubilité
In Vitro:
H2O : ≥ 100 mg/mL
* "≥" means soluble, but saturation unknown.
Protocole
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
Pureté et documentation
-
Fiche technique (272 KB)
-
SDS (925 KB)
- English - EN (925 KB)
- Français - FR (925 KB)
- Deutsch - DE (925 KB)
- Norwegian - NO (925 KB)
- Español - ES (925 KB)
- Swedish - SV (925 KB)
- Italian - IT (925 KB)
- Korean - KR (925 KB)
- Portuguese - PT (925 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Singh N, et al. Subtilisin from Bacillus amyloliquefaciens induces apoptosis in breast cancer cells through ubiquitin-proteasome-mediated tubulin degradation. Int J Biol Macromol. 2022 Nov 1;220:852-865. [Content Brief]
[2]. Leroy C, et al. Influence of subtilisin on the adhesion of a marine bacterium which produces mainly proteins as extracellular polymers. J Appl Microbiol. 2008 Sep;105(3):791-9. [Content Brief]
[3]. Alexander PA, et al. Stabilizing mutations and calcium-dependent stability of subtilisin. Biochemistry. 2001 Sep 4;40(35):10640-4. [Content Brief]
[4]. Florsheim E, et al. Integrated innate mechanisms involved in airway allergic inflammation to the serine protease subtilisin. J Immunol. 2015 May 15;194(10):4621-30. [Content Brief]
[5]. Azrin NAM, et al. Versatility of subtilisin: A review on structure, characteristics, and applications. Biotechnol Appl Biochem. 2022 Dec;69(6):2599-2616. [Content Brief]
[6]. Philipp M, et al. Kinetics of subtilisin and thiolsubtilisin. Mol Cell Biochem. 1983;51(1):5-32. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)